The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer

References

• Siegel R, Ma J, Zou Z, and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64, 9–29, 2014. doi: 10.3322/caac.21208
   PubMed Web of Science ®Google Scholar
• Richter E, Denecke A, Klapdor S, and Klapdor R: Parenteral nutrition support for patients with pancreatic cancer–improvement of the nutritional status and the therapeutic outcome. Anticancer Res 32, 2111–2118, 2012.
   PubMed Web of Science ®Google Scholar
• Vashi P, Popiel B, Lammersfeld C, and Gupta D: Outcomes of systematic nutritional assessment and medical nutrition therapy in pancreatic cancer. Pancreas 44, 750–755, 2015. doi: 10.1097/MPA.0000000000000336
   PubMed Web of Science ®Google Scholar
• Bye A, Jordhoy MS, Skjegstad G, Ledsaak O, Iversen PO, et al.: Symptoms in advanced pancreatic cancer are of importance for energy intake. Support Care Cancer 21, 219–227, 2013. doi: 10.1007/s00520-012-1514-8
   PubMed Web of Science ®Google Scholar
• Cohen SJ, Pinover WH, Watson JC, and Meropol NJ: Pancreatic cancer. Curr Treat Options Oncol 1, 375–386, 2000.
   PubMedGoogle Scholar
• Mueller TC, Burmeister MA, Bachmann J, and Martignoni ME: Cachexia and pancreatic cancer: are there treatment options? World J Gastroenterol 20, 9361–9373, 2014. doi: 10.3748/wjg.v20.i28.9361
   PubMed Web of Science ®Google Scholar
• Ronga I, Gallucci F, Riccardi F, and Uomo G: Anorexia-cachexia syndrome in pancreatic cancer: recent advances and new pharmacological approach. Adv Med Sci 59, 1–6, 2014. doi: 10.1016/j.advms.2013.11.001
   PubMed Web of Science ®Google Scholar
• Kondrup J, Allison SP, Elia M, Vellas B, Plauth M, et al.: ESPEN guidelines for nutrition screening 2002. Clin Nutr 22, 415–421, 2003.
   PubMed Web of Science ®Google Scholar
• Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, et al.: Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12, 489–495, 2011. doi: 10.1016/S1470-2045(10)70218-7
   PubMed Web of Science ®Google Scholar
• Onodera T, Goseki N, and Kosaki G: Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85, 1001–1005, 1984.
   PubMedGoogle Scholar
• Watanabe M, Iwatsuki M, Iwagami S, Ishimoto T, Baba Y, et al.: Prognostic nutritional index predicts outcomes of gastrectomy in the elderly. World J Surg 36, 1632–1639, 2012. doi: 10.1007/s00268-012-1526-z
   PubMed Web of Science ®Google Scholar
• Kang SH, Cho KH, Park JW, Yoon KW, and Do JY: Onodera's prognostic nutritional index as a risk factor for mortality in peritoneal dialysis patients. J Korean Med Sci 27, 1354–1358, 2012. doi: 10.3346/jkms.2012.27.11.1354
   PubMed Web of Science ®Google Scholar
• Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, et al.: Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg 98, 268–274, 2011. doi: 10.1002/bjs.7305
   PubMed Web of Science ®Google Scholar
• Feng JF and Chen QX: Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma. Ther Clin Risk Manage 10, 1–7, 2014. doi: 10.2147/TCRM.S56159
   PubMed Web of Science ®Google Scholar
• Nozoe T, Kohno M, Iguchi T, Mori E, Maeda T, et al.: The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg Today 42, 532–535, 2012. doi: 10.1007/s00595-011-0061-0
   PubMed Web of Science ®Google Scholar
• Qiu C, Qu X, Shen H, Zheng C, Zhu L, et al.: Evaluation of prognostic nutritional index in patients undergoing radical surgery with nonsmall cell lung cancer. Nutr Cancer 67, 741–47, 2015. doi: 10.1080/01635581.2015.1032430
   PubMed Web of Science ®Google Scholar
• Geng Y, Qi Q, Sun M, Chen H, Wang P, et al.: Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer. Eur J Surg Oncol 41, 1508–1514, 2015. doi: 10.1016/j.ejso.2015.07.022
   PubMed Web of Science ®Google Scholar
• Wigmore SJ, Plester CE, Richardson RA, and Fearon KC: Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75, 106–109, 1997.
   PubMed Web of Science ®Google Scholar
• Tan CR, Yaffee PM, Jamil LH, Lo SK, Nissen N, et al.: Pancreatic cancer cachexia: a review of mechanisms and therapeutics. Front Physiol 5, 88, 2014. doi: 10.3389/fphys.2014.00088
   PubMed Web of Science ®Google Scholar
• Fearon KC and Baracos VE: Cachexia in pancreatic cancer: new treatment options and measures of success. HPB (Oxford) 12, 323–324, 2010. doi: 10.1111/j.1477-2574.2010.00178.x
   PubMed Web of Science ®Google Scholar
• Mullen JL, Buzby GP, Matthews DC, Smale BF, and Rosato EF: Reduction of operative morbidity and mortality by combined preoperative and postoperative nutritional support. Ann Surg 192, 604–613, 1980.
   PubMed Web of Science ®Google Scholar
• Doweiko JP and Nompleggi DJ: The role of albumin in human physiology and pathophysiology, Part III: Albumin and disease states. JPEN J Parenter Enteral Nutr 15, 476–483, 1991.
   PubMed Web of Science ®Google Scholar
• Lien YC, Hsieh CC, Wu YC, Hsu HS, Hsu WH, et al.: Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastrointest Surg 8, 1041–8, 2004. doi: 10.1016/j.gassur.2004.09.033
   PubMed Web of Science ®Google Scholar
• Uppal S, Al-Niaimi A, Rice LW, Rose SL, Kushner DM, et al.: Preoperative hypoalbuminemia is an independent predictor of poor perioperative outcomes in women undergoing open surgery for gynecologic malignancies. Gynecol Oncol 131, 416–422, 2013. doi: 10.1016/j.ygyno.2013.08.011
   PubMed Web of Science ®Google Scholar
• Lohsiriwat V, Lohsiriwat D, Boonnuch W, Chinswangwatanakul V, Akaraviputh T, et al.: Pre-operative hypoalbuminemia is a major risk factor for postoperative complications following rectal cancer surgery. World J Gastroenterol 14, 1248–1251, 2008.
   PubMed Web of Science ®Google Scholar
• Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357, 539–545, 2001. doi: 10.1016/S0140-6736(00)04046-0
   PubMed Web of Science ®Google Scholar
• Balmanoukian A, Ye X, Herman J, Laheru D, and Grossman SA: The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas. Cancer Invest 30, 571–576, 2012. doi: 10.3109/07357907.2012.700987
   PubMed Web of Science ®Google Scholar
• Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, et al.: Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas 32, 22–28, 2006.
   PubMed Web of Science ®Google Scholar
• Nozoe T, Ninomiya M, Maeda T, Matsukuma A, Nakashima H, et al.: Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today 40, 440–443, 2010. doi: 10.1007/s00595-009-4065-y
   PubMed Web of Science ®Google Scholar
• Sun K, Chen S, Xu J, Li G, and He Y: The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol 140, 1537–49, 2014. doi: 10.1007/s00432-014-1714-3
   PubMed Web of Science ®Google Scholar
• Roxburgh CS and McMillan DC: Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6, 149–163, 2010. doi: 10.2217/fon.09.136
   PubMed Web of Science ®Google Scholar
• Knight BC, Kausar A, Manu M, Ammori BA, Sherlock DJ, et al.: Evaluation of surgical outcome scores according to ISGPS definitions in patients undergoing pancreatic resection. Dig Surg 27, 367–374, 2010. doi: 10.1159/000313693
   PubMed Web of Science ®Google Scholar
• Glen P, Jamieson NB, McMillan DC, Carter R, Imrie CW, et al.: Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6, 450–453, 2006. doi: 10.1159/000094562
   PubMed Web of Science ®Google Scholar
• Wang DS, Luo HY, Qiu MZ, Wang ZQ, Zhang DS, et al.: Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol 29, 3092–3100, 2012. doi: 10.1007/s12032-012-0226-8
   PubMed Web of Science ®Google Scholar
• An X, Ding PR, Li YH, Wang FH, Shi YX, et al.: Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers 15, 516–522, 2010. doi: 10.3109/1354750X.2010.491557
   PubMed Web of Science ®Google Scholar
• Xue P, Kanai M, Mori Y, Nishimura T, Uza N, et al.: Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. Cancer Med 3, 406–415, 2014. doi: 10.1002/cam4.204
   PubMed Web of Science ®Google Scholar
• Bhatti I, Peacock O, Lloyd G, Larvin M, and Hall RI: Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg 200, 197–203, 2010. doi: 10.1016/j.amjsurg.2009.08.041
   PubMed Web of Science ®Google Scholar
• Ikeda M, Okada S, Tokuuye K, Ueno H, and Okusaka T: Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy. Cancer 91, 490–495, 2001.
   PubMed Web of Science ®Google Scholar
• Krishnan S, Rana V, Janjan NA, Abbruzzese JL, Gould MS, et al.: Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. Cancer 107, 2589–2596, 2006. doi: 10.1002/cncr.22328
   PubMed Web of Science ®Google Scholar
• Tas F, Sen F, Odabas H, Kilic L, Keskin S, et al.: Performance status of patients is the major prognostic factor at all stages of pancreatic cancer. Int J Clin Oncol 18, 839–846, 2013. doi: 10.1007/s10147-012-0474-9
   PubMed Web of Science ®Google Scholar
• Chadha AS, Kocak-Uzel E, Das P, Minsky BD, Delclos ME, et al.: Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. Acta Oncol 54, 971–978, 2015. doi: 10.3109/0284186X.2014.1000466
   PubMed Web of Science ®Google Scholar